{"id":"ferrous-gluconate","rwe":[{"pmid":"41839045","year":"2026","title":"Fat Apoptosis Injection Therapy for Infraorbital Herniated Fat Pads.","finding":"","journal":"The Journal of craniofacial surgery","studyType":"Clinical Study"},{"pmid":"34958537","year":"2006","title":"Iron Salts.","finding":"","journal":"","studyType":"Clinical Study"},{"pmid":"41679208","year":"2026","title":"Evaluation of iron supplementation effects of whey protein peptide-ferrous chelate: enhancing bioavailability and antioxidant capacity, promoting gut microbiota balance.","finding":"","journal":"Food chemistry","studyType":"Clinical Study"},{"pmid":"41660502","year":"2026","title":"Oral iron preparations: gastrointestinal adverse events and medication adherence in female patients with iron deficiency anemia.","finding":"","journal":"Frontiers in pharmacology","studyType":"Clinical Study"},{"pmid":"41347233","year":"2025","title":"Economic evaluation of intravenous iron formulations for patients with iron deficiency anemia: a systematic review.","finding":"","journal":"Frontiers in health services","studyType":"Clinical Study"}],"_fda":{"id":"3c362de4-1eda-83be-e063-6394a90a10fc","set_id":"3c362de4-1ed9-83be-e063-6394a90a10fc","openfda":{"nui":["N0000193618","M0001797","M0022797","N0000175952"],"unii":["PQ6CK8PD0R","H0G9379FGK","1C6V77QF41","U1B11I423Z","935E97BOY8","BR1SN1JS2W","1C4QK22F9J","F06SGE49M6","X66NSO3N35"],"route":["ORAL"],"spl_id":["3c362de4-1eda-83be-e063-6394a90a10fc"],"brand_name":["Embriva"],"spl_set_id":["3c362de4-1ed9-83be-e063-6394a90a10fc"],"package_ndc":["85477-322-30"],"product_ndc":["85477-322"],"generic_name":["ASCORBIC ACID, CHOLECALCIFEROL, THIAMINE, PYRIDOXAL PHOSPHATE, FOLIC ACID, METHYLCOBALAMIN, CALCIUM CARBONATE, FERROUS GLUCONATE, POTASSIUM IODIDE"],"product_type":["HUMAN PRESCRIPTION DRUG"],"pharm_class_cs":["Ascorbic Acid [CS]","Vitamin D [CS]"],"substance_name":["ASCORBIC ACID","CALCIUM CARBONATE","CHOLECALCIFEROL","FERROUS GLUCONATE","FOLIC ACID","METHYLCOBALAMIN","POTASSIUM IODIDE","PYRIDOXAL PHOSPHATE ANHYDROUS","THIAMINE"],"pharm_class_epc":["Vitamin C [EPC]","Vitamin D [EPC]"],"manufacturer_name":["Oncora Pharma, LLC"],"is_original_packager":[true]},"version":"1","warnings":["WARNINGS WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under age 6. Keep this product out of the reach of children. In case of accidental overdose, call a doctor or Poison Control Center immediately."],"description":["DESCRIPTION Each Tablet Contains: Amount per Tablet Thiamine (Vitamin B-1) (from Thiamine Mononitrate) ................. 1.4 mg Ascorbic Acid...................... ......................................................... 125 mg Folic Acid ....................................................................................... 1 mg Colecalciferol ............................................................................. .0125 mg Pyridoxal Phosphate Anhydrous ................................................. 2.5 mg Methylcobalamin.................. ........................................................ 1 mg Calcium Carbonate ................................................................... 200 mg Ferrous Gluconate ..................................................................... 13 mg Potassium Iodide........................................................................ .15 mg Other ingredients: magnesium stearate, microcrystalline cellulose, silicone dioxide"],"precautions":["PRECAUTIONS Call your licensed medical practitioner about side effects."],"how_supplied":["HOW SUPPLIED Bottles of 30: 85477-0322-30 Storage KEEP THIS AND ALL MEDICATION OUR OF THE REACH OF CHILDREN."],"effective_time":"20250812","warnings_table":["<table><col/><tbody><tr><td styleCode=\" Botrule Toprule Lrule Rrule\"><content styleCode=\"bold\">WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under age 6. Keep this product out of the reach of children. In case of accidental overdose, call a doctor or Poison Control Center immediately.</content><content styleCode=\"bold\"> </content></td></tr></tbody></table>"],"storage_and_handling":["Storage KEEP THIS AND ALL MEDICATION OUR OF THE REACH OF CHILDREN."],"indications_and_usage":["INDICATIONS AND USAGE Prenatal and Postnatal prescriptive Folic Acid"],"dosage_and_administration":["DOSAGE AND ADMINISTRATION Usual adult dose is 1 tablet once or twice daily or as prescribed by a licensed practitioner."],"spl_product_data_elements":["Embriva ASCORBIC ACID, CHOLECALCIFEROL, THIAMINE, PYRIDOXAL PHOSPHATE, FOLIC ACID, METHYLCOBALAMIN, CALCIUM CARBONATE, FERROUS GLUCONATE, POTASSIUM IODIDE PYRIDOXAL PHOSPHATE ANHYDROUS PYRIDOXAL PHOSPHATE ANHYDROUS POTASSIUM IODIDE IODIDE ION MAGNESIUM STEARATE CELLULOSE, MICROCRYSTALLINE SILICON DIOXIDE ASCORBIC ACID ASCORBIC ACID CHOLECALCIFEROL CHOLECALCIFEROL THIAMINE THIAMINE ION FOLIC ACID FOLIC ACID METHYLCOBALAMIN METHYLCOBALAMIN CALCIUM CARBONATE CALCIUM CATION FERROUS GLUCONATE FERROUS CATION"],"package_label_principal_display_panel":["PRINCIPAL DISPLAY PANEL label"]},"tags":[{"label":"Parenteral Iron Replacement","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"B03AA03","category":"atc"},{"label":"Oral","category":"route"},{"label":"Intravenous","category":"route"},{"label":"Injection","category":"form"},{"label":"Tablet","category":"form"},{"label":"Active","category":"status"},{"label":"Anemia of prematurity","category":"indication"},{"label":"Iron deficiency anemia","category":"indication"},{"label":"Sanofi Aventis Us","category":"company"},{"label":"Approved 1990s","category":"decade"},{"label":"Hematinics","category":"pharmacology"},{"label":"Hematologic Agents","category":"pharmacology"}],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[{"llr":483.681,"date":"","count":157,"signal":"Appendicolith","source":"DrugCentral FAERS","actionTaken":"Reported 157 times (LLR=484)"},{"llr":330.574,"date":"","count":157,"signal":"Appendicitis","source":"DrugCentral FAERS","actionTaken":"Reported 157 times (LLR=331)"},{"llr":247.217,"date":"","count":161,"signal":"Cardiogenic shock","source":"DrugCentral FAERS","actionTaken":"Reported 161 times (LLR=247)"},{"llr":230.971,"date":"","count":73,"signal":"Presbyacusis","source":"DrugCentral FAERS","actionTaken":"Reported 73 times (LLR=231)"},{"llr":221.522,"date":"","count":64,"signal":"Reversible airways obstruction","source":"DrugCentral FAERS","actionTaken":"Reported 64 times (LLR=222)"},{"llr":216.181,"date":"","count":62,"signal":"Vital capacity decreased","source":"DrugCentral FAERS","actionTaken":"Reported 62 times (LLR=216)"},{"llr":198.22,"date":"","count":73,"signal":"Pleural fibrosis","source":"DrugCentral FAERS","actionTaken":"Reported 73 times (LLR=198)"},{"llr":187.482,"date":"","count":64,"signal":"Pleural thickening","source":"DrugCentral FAERS","actionTaken":"Reported 64 times (LLR=187)"},{"llr":180.52,"date":"","count":62,"signal":"Sputum culture positive","source":"DrugCentral FAERS","actionTaken":"Reported 62 times (LLR=181)"},{"llr":177.814,"date":"","count":184,"signal":"Stress","source":"DrugCentral FAERS","actionTaken":"Reported 184 times (LLR=178)"},{"llr":177.552,"date":"","count":422,"signal":"Abdominal pain","source":"DrugCentral FAERS","actionTaken":"Reported 422 times (LLR=178)"},{"llr":176.193,"date":"","count":177,"signal":"Ascites","source":"DrugCentral FAERS","actionTaken":"Reported 177 times (LLR=176)"},{"llr":173.471,"date":"","count":63,"signal":"Blood magnesium increased","source":"DrugCentral FAERS","actionTaken":"Reported 63 times (LLR=173)"},{"llr":172.261,"date":"","count":62,"signal":"Bronchial secretion retention","source":"DrugCentral FAERS","actionTaken":"Reported 62 times (LLR=172)"},{"llr":171.483,"date":"","count":79,"signal":"Blood phosphorus increased","source":"DrugCentral FAERS","actionTaken":"Reported 79 times (LLR=171)"}],"drugInteractions":[{"url":"/drug/dolutegravir","drug":"dolutegravir","action":"Monitor closely","effect":"May interact with Dolutegravir","source":"DrugCentral","drugSlug":"dolutegravir"},{"url":"/drug/dolutegravir","drug":"dolutegravir","action":"Monitor closely","effect":"May interact with Dolutegravir, Iron","source":"DrugCentral","drugSlug":"dolutegravir"},{"url":"/drug/enoxacin","drug":"enoxacin","action":"Monitor closely","effect":"May interact with Enoxacin","source":"DrugCentral","drugSlug":"enoxacin"},{"url":"/drug/enoxacin","drug":"enoxacin","action":"Monitor closely","effect":"May interact with Enoxacin, Iron","source":"DrugCentral","drugSlug":"enoxacin"},{"url":"/drug/gatifloxacin","drug":"gatifloxacin","action":"Monitor closely","effect":"May interact with Gatifloxacin","source":"DrugCentral","drugSlug":"gatifloxacin"},{"url":"/drug/levodopa","drug":"levodopa","action":"Monitor closely","effect":"May interact with Levodopa","source":"DrugCentral","drugSlug":"levodopa"},{"url":"/drug/levodopa","drug":"levodopa","action":"Monitor closely","effect":"May interact with Iron, Levodopa","source":"DrugCentral","drugSlug":"levodopa"},{"url":"/drug/levofloxacin","drug":"levofloxacin","action":"Monitor closely","effect":"May interact with Levofloxacin","source":"DrugCentral","drugSlug":"levofloxacin"},{"url":"/drug/levofloxacin","drug":"levofloxacin","action":"Monitor closely","effect":"May interact with Iron, Levofloxacin","source":"DrugCentral","drugSlug":"levofloxacin"},{"url":"/drug/levothyroxine-sodium","drug":"levothyroxine sodium","action":"Monitor closely","effect":"May interact with Levothyroxine Sodium","source":"DrugCentral","drugSlug":"levothyroxine-sodium"},{"url":"/drug/levothyroxine-sodium","drug":"levothyroxine sodium","action":"Monitor closely","effect":"May interact with Iron, Levothyroxine Sodium","source":"DrugCentral","drugSlug":"levothyroxine-sodium"},{"url":"/drug/lomefloxacin","drug":"lomefloxacin","action":"Monitor closely","effect":"May interact with Iron, Lomefloxacin","source":"DrugCentral","drugSlug":"lomefloxacin"},{"url":"/drug/minocycline","drug":"minocycline","action":"Monitor closely","effect":"May interact with Minocycline","source":"DrugCentral","drugSlug":"minocycline"},{"url":"/drug/minocycline","drug":"minocycline","action":"Monitor closely","effect":"May interact with Iron, Minocycline","source":"DrugCentral","drugSlug":"minocycline"},{"url":"/drug/moxifloxacin","drug":"moxifloxacin","action":"Monitor closely","effect":"May interact with Moxifloxacin","source":"DrugCentral","drugSlug":"moxifloxacin"},{"url":"/drug/moxifloxacin","drug":"moxifloxacin","action":"Monitor closely","effect":"May interact with Iron, Moxifloxacin","source":"DrugCentral","drugSlug":"moxifloxacin"},{"url":"/drug/mycophenolate-mofetil","drug":"mycophenolate mofetil","action":"Monitor closely","effect":"May interact with Iron, Mycophenolate Mofetil","source":"DrugCentral","drugSlug":"mycophenolate-mofetil"},{"url":"/drug/norfloxacin","drug":"norfloxacin","action":"Monitor closely","effect":"May interact with Norfloxacin","source":"DrugCentral","drugSlug":"norfloxacin"},{"url":"/drug/norfloxacin","drug":"norfloxacin","action":"Monitor closely","effect":"May interact with Iron, Norfloxacin","source":"DrugCentral","drugSlug":"norfloxacin"},{"url":"/drug/ofloxacin","drug":"ofloxacin","action":"Monitor closely","effect":"May interact with Ofloxacin","source":"DrugCentral","drugSlug":"ofloxacin"}],"commonSideEffects":[],"contraindications":["Diverticular disease","Gastroenteritis","Hemochromatosis","Hemolytic anemia","Hemosiderosis","Peptic ulcer","Repeated Blood Transfusions","Ulcerative colitis"],"specialPopulations":{"Lactation":"Not recommended when breastfeeding. Ferrlecit contains benzyl alcohol. Because benzyl alcohol is rapidly metabolized by lactating woman, benzyl alcohol exposure in the breastfed infant is unlikely. However, adverse reactions have occurred in premature neonates and low-birth-weight infants who received intravenously administered benzyl alcohol-containing drugs. Consider alternative iron replacement therapies without benzyl alcohol","Pregnancy":"Risk of hypersensitivity reaction which may have serious consequences for the fetus. Use only if clearly needed (contains benzyl alcohol). Parenteral iron administration may be associated with hypersensitivity reactions, which may have serious consequences, such as fetal bradycardia. Ferrlecit contains benzyl alcohol as preservative. Because benzyl alcohol is rapidly metabolized by pregnant woman, benzyl alcohol exposure in the fetus is unlikely. However, adverse reactions have occurred in premature neonates and low-birth-weight infants who received intravenously administered benzyl alcohol-containing drugs.","Geriatric use":"Clinical studies of sodium ferric gluconate complex in sucrose injection did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy with potential for interaction with sodium ferric gluconate complex in sucrose injection.","Paediatric use":"Safety and effectiveness have not been established in pediatric patients <6 years of age. The safety and effectiveness of sodium ferric gluconate complex in sucrose injection have been established in pediatric patients to 15 years of age. Sodium ferric gluconate complex in sucrose injection is not approved for use in neonates or infants."}},"trials":[],"aliases":[],"company":"Sanofi","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=FERROUS GLUCONATE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:57:36.832714+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-20T01:58:04.219441+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:57:48.630960+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=FERROUS GLUCONATE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:57:49.413773+00:00"},"mechanism.drugClass":{"url":"https://api.fda.gov/drug/label.json","method":"deterministic","source":"FDA Label (EPC)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:57:34.616999+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:57:34.617033+00:00"},"indications.approved":{"url":"","method":"ai_extraction","source":"FDA Label + AI","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:57:57.071246+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:57:34.617042+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3833303/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:57:49.893494+00:00"}},"allNames":"glucoferron","offLabel":[],"synonyms":["sodium ferric gluconate complex","ferrous gluconate","iron gluconate","ferroglyconicum","glucoferron"],"timeline":[{"date":"1999-02-18","type":"positive","source":"DrugCentral","milestone":"FDA approval (Sanofi Aventis Us)"}],"aiSummary":"Glucoferron, marketed by Sanofi, is an iron supplement primarily indicated for prenatal and postnatal folic acid supplementation, competing in a well-established market with other iron sources like ferrous fumarate and ferrous sulfate. Its key strength lies in its mechanism of replenishing iron stores effectively, supported by a key composition patent expiring in 2028. The primary risk to Glucoferron is the strong competition from generic alternatives, which have been on the market since 1946 and 1986, respectively.","approvals":[{"date":"1999-02-18","orphan":false,"company":"SANOFI AVENTIS US","regulator":"FDA"}],"brandName":"Glucoferron","ecosystem":[{"indication":"Anemia of prematurity","otherDrugs":[{"name":"ferric oxide","slug":"ferric-oxide","company":""},{"name":"ferrous fumarate","slug":"ferrous-fumarate","company":"Gd Searle Llc"},{"name":"ferrous sulfate","slug":"ferrous-sulfate","company":"Lederle"},{"name":"iron","slug":"iron","company":""}],"globalPrevalence":null},{"indication":"Iron deficiency anemia","otherDrugs":[{"name":"cyanocobalamin","slug":"cyanocobalamin","company":""},{"name":"docusate sodium","slug":"docusate-sodium","company":""},{"name":"ferric carboxymaltose","slug":"ferric-carboxymaltose","company":"Luitpold"},{"name":"ferric citrate","slug":"ferric-citrate","company":"Keryx Biopharms"}],"globalPrevalence":null}],"mechanism":{"novelty":"Follow-on","modality":"Small Molecule","drugClass":"Vitamin C [EPC]","explanation":"","oneSentence":"","technicalDetail":"Glucoferron is a ferrous salt that is absorbed into the bloodstream and then transported to the liver, where it is stored and eventually released into the bloodstream to be utilized by the body's cells."},"commercial":{"launchDate":"1999","_launchSource":"DrugCentral (FDA 1999-02-18, SANOFI AVENTIS US)"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4491","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=FERROUS%20GLUCONATE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=FERROUS GLUCONATE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T13:44:47.544574","_validation":{"fieldsValidated":2,"lastValidatedAt":"2026-04-20T01:58:04.219858+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"ferrous fumarate","drugSlug":"ferrous-fumarate","fdaApproval":"1986-07-18","relationship":"same-class"},{"drugName":"ferrous sulfate","drugSlug":"ferrous-sulfate","fdaApproval":"1946-08-13","relationship":"same-class"}],"genericName":"ferrous gluconate","indications":{"approved":[{"id":"ferrous-gluconate-prenatal-and-postnatal-folic-a","name":"Prenatal and Postnatal Folic Acid Supplementation","dosing":null,"approvals":[],"diseaseId":"","eligibility":"Pregnant women and postpartum women","pivotalTrial":null,"restrictions":[],"patientPopulation":"Pregnant women and postpartum women","diagnosticRequired":null,"brandNameForIndication":"Glucoferron"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"ferrous-fumarate","brandName":"ferrous fumarate","genericName":"ferrous fumarate","approvalYear":"1986","relationship":"same-class"},{"drugId":"ferrous-sulfate","brandName":"ferrous sulfate","genericName":"ferrous sulfate","approvalYear":"1946","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT07366502","phase":"NA","title":"Liposomal vs Conventional Oral Iron After Sleeve Gastrectomy","status":"RECRUITING","sponsor":"Medeni Şermet","startDate":"2025-09-01","conditions":["İron Deficiency Anemia","Liposomal Iron Replacement","Conventional Iron Replacement"],"enrollment":70,"completionDate":"2026-12-31"},{"nctId":"NCT05681871","phase":"PHASE4","title":"South African Paediatric Surgical Outcomes Study 2","status":"COMPLETED","sponsor":"University of Cape Town","startDate":"2023-02-09","conditions":["Paediatric Surgery","Anaemia","Iron Deficiency Anemia","Iron","Prospective Studies","Interventional Studies"],"enrollment":755,"completionDate":"2025-05-31"},{"nctId":"NCT06066151","phase":"NA","title":"The Efficacy of Minayo Iron-rich Yeast Drink With SOD on Female Nutritional Anemia, Skin Condition and Qi-blood Deficiency Syndrome","status":"COMPLETED","sponsor":"Hangzhou Agile Groups Network Technology Co., Ltd.","startDate":"2023-09-10","conditions":["Anemia","Skin Condition"],"enrollment":11,"completionDate":"2023-12-15"},{"nctId":"NCT06869824","phase":"NA","title":"The Efficacy of Minayo Iron-rich Nutritional Gummies on Female Anemia, Skin Condition and Qi-blood Deficiency Syndrome","status":"COMPLETED","sponsor":"Hangzhou Agile Groups Network Technology Co., Ltd.","startDate":"2025-03-17","conditions":["Anemia","Skin Condition","Qi-blood Deficiency Syndrome"],"enrollment":36,"completionDate":"2025-04-13"},{"nctId":"NCT06642337","phase":"NA","title":"Nutritional Educational Program On Therapy in Iron Deficiency Anemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hawler Medical University","startDate":"2025-02-01","conditions":["Iron Deficiency Anemia (IDA)","Nutrition Disorders","Growth Retardation"],"enrollment":150,"completionDate":"2026-09-01"},{"nctId":"NCT06049693","phase":"PHASE4","title":"Iron Prehabilitation in Endometrial Cancer","status":"COMPLETED","sponsor":"National and Kapodistrian University of Athens","startDate":"2023-01-01","conditions":["Endometrial Cancer","Perioperative Complication","Prehabilitation"],"enrollment":156,"completionDate":"2024-01-01"},{"nctId":"NCT06252103","phase":"PHASE4","title":"Lactoferrin With Ferrous Gluconate Versus Ferrous Gluconate in Treatment of Iron Deficiency Anemia During Pregnancy","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-05-30","conditions":["Lactoferrin With Ferrous Gluconate More Superior Than Ferrous Gluconate Alone in Treatment of Iron Deficiency Anemia"],"enrollment":40,"completionDate":"2023-12-30"},{"nctId":"NCT02245321","phase":"NA","title":"Strategies to Reduce Iron Deficiency","status":"COMPLETED","sponsor":"Westat","startDate":"2011-06","conditions":["Iron Deficiency"],"enrollment":702,"completionDate":"2014-06"},{"nctId":"NCT01414075","phase":"PHASE2","title":"Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis-Stimulating Agent Treatment","status":"COMPLETED","sponsor":"Kyntra Bio","startDate":"2011-07-21","conditions":["Dialysis","Anemia"],"enrollment":60,"completionDate":"2013-01-10"},{"nctId":"NCT01752413","phase":"NA","title":"Iron Depletion and Replacement in Blood Donors","status":"COMPLETED","sponsor":"Memorial Blood Centers, Minnesota","startDate":"2012-12","conditions":["Anemia"],"enrollment":197,"completionDate":"2014-11"},{"nctId":"NCT00223938","phase":"PHASE4","title":"Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.","status":"TERMINATED","sponsor":"Sanofi","startDate":"2003-12-30","conditions":["Anemia"],"enrollment":112,"completionDate":"2007-04-27"},{"nctId":"NCT02228902","phase":"PHASE4","title":"Iron Absorption Trial","status":"COMPLETED","sponsor":"Rijnstate Hospital","startDate":"2014-08","conditions":["Iron Absorption","Bariatric Surgery","Roux- en -y Gastric Bypass"],"enrollment":24,"completionDate":"2015-05-04"},{"nctId":"NCT02233322","phase":"NA","title":"Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project.","status":"COMPLETED","sponsor":"Indiana University","startDate":"2014-08","conditions":["Autosomal Dominant Hypophosphatemic Rickets"],"enrollment":8,"completionDate":"2019-11-12"},{"nctId":"NCT02271997","phase":"PHASE4","title":"Optimizing Iron Suppletion After Roux-en-Y Gastric Bypass","status":"COMPLETED","sponsor":"Rijnstate Hospital","startDate":"2014-12-04","conditions":["Iron Deficiency"],"enrollment":120,"completionDate":"2017-06-06"},{"nctId":"NCT02300428","phase":"","title":"Health Economics of the Use of Ferrous Iron Salts in Primary Care in the UK.","status":"COMPLETED","sponsor":"dora pereira","startDate":"2014-11","conditions":["Anemia"],"enrollment":406902,"completionDate":"2017-12"},{"nctId":"NCT00704353","phase":"PHASE3","title":"Safety and Tolerability of a Single Dose of FCM vs. Standard of Care in Treating Iron Deficiency Anemia","status":"COMPLETED","sponsor":"American Regent, Inc.","startDate":"2008-06","conditions":["Anemia"],"enrollment":735,"completionDate":"2011-03"},{"nctId":"NCT02593136","phase":"NA","title":"Home Fortification of Complementary Foods in Bihar India","status":"COMPLETED","sponsor":"Emory University","startDate":"2014-06","conditions":["Anemia","Malnutrition"],"enrollment":11861,"completionDate":"2016-03"},{"nctId":"NCT02610881","phase":"NA","title":"Acceptability and Feasibility of Micronutrient Powders Versus Iron Syrup for Anemia Prevention in Young Children","status":"COMPLETED","sponsor":"Emory University","startDate":"2015-12","conditions":["Anemia"],"enrollment":110,"completionDate":"2016-04"},{"nctId":"NCT02073149","phase":"PHASE2,PHASE3","title":"Safe and Efficacious Iron for Children in Kenya","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2014-06","conditions":["Anaemia"],"enrollment":338,"completionDate":"2014-12"},{"nctId":"NCT02221752","phase":"NA","title":"Impact of Iron/Folic Acid vs Folic Acid Supplements During Pregnancy on Maternal and Child Health","status":"COMPLETED","sponsor":"Zhao gengli","startDate":"2009-06","conditions":["Iron Deficiency","Iron Deficiency Anemia"],"enrollment":2367,"completionDate":"2011-12"},{"nctId":"NCT01611181","phase":"PHASE1","title":"Iron Substitution After Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Northern Orthopaedic Division, Denmark","startDate":"2006-05","conditions":["Haemodynamic Rebound"],"enrollment":72,"completionDate":"2007-06"},{"nctId":"NCT01555060","phase":"PHASE2","title":"Hemoglobin and Iron Recovery Study","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2012-03","conditions":["Recovery of Hemoglobin and Iron Stores After Blood Donation"],"enrollment":215,"completionDate":"2013-06"},{"nctId":"NCT00223977","phase":"PHASE2,PHASE3","title":"2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.","status":"COMPLETED","sponsor":"Watson Pharmaceuticals","startDate":"2003-12","conditions":["Iron Deficiency Anemia"],"enrollment":146,"completionDate":"2008-02"},{"nctId":"NCT01528644","phase":"NA","title":"Iron & Alginate Study","status":"COMPLETED","sponsor":"University of East Anglia","startDate":"2012-02","conditions":["Iron Deficiency","Anaemia"],"enrollment":16,"completionDate":"2013-01"},{"nctId":"NCT00224055","phase":"PHASE4","title":"Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients","status":"COMPLETED","sponsor":"Watson Pharmaceuticals","startDate":"2003-04","conditions":["Anemia, Iron-Deficiency","Kidney Failure, Chronic"],"enrollment":89,"completionDate":"2004-09"},{"nctId":"NCT00224042","phase":"PHASE4","title":"Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic Agents","status":"COMPLETED","sponsor":"Watson Pharmaceuticals","startDate":"2003-04","conditions":["Anemia, Iron-Deficiency","Kidney Failure, Chronic"],"enrollment":52,"completionDate":""},{"nctId":"NCT00224068","phase":"PHASE4","title":"Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy","status":"COMPLETED","sponsor":"Watson Pharmaceuticals","startDate":"2002-05","conditions":["Anemia"],"enrollment":180,"completionDate":"2003-12"},{"nctId":"NCT00661999","phase":"PHASE3","title":"Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2006-01","conditions":["Anemia","Leukemia","Lymphoma","Lymphoproliferative Disorder","Multiple Myeloma and Plasma Cell Neoplasm","Precancerous Condition","Unspecified Adult Solid Tumor, Protocol Specific"],"enrollment":502,"completionDate":"2009-03"},{"nctId":"NCT00248716","phase":"PHASE4","title":"Treatment of Anemia in the 2nd Year of Life. Comparison of the Efficacy of Two Different Iron Preparations.","status":"UNKNOWN","sponsor":"Soroka University Medical Center","startDate":"2007-02","conditions":["Iron Deficiency","Anemia"],"enrollment":200,"completionDate":""}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Oral","formulation":"Injection, Tablet","formulations":[{"form":"INJECTION","route":"INTRAVENOUS","productName":"Sodium Ferric Gluconate Complex in Sucrose"},{"form":"INJECTION","route":"INTRAVENOUS","productName":"Ferrlecit"},{"form":"TABLET","route":"ORAL","productName":"CitraNatal 90 DHA"},{"form":"TABLET, FILM COATED","route":"ORAL","productName":"BioFerr 90"},{"form":"TABLET, FILM COATED","route":"ORAL","productName":"CitraNatal Bloom"}]},"crossReferences":{"NUI":"N0000148626","MMSL":"189358","NDDF":"000834","UNII":"U1B11I423Z","VUID":"4024159","CHEBI":"CHEBI:31608","VANDF":"4017678","RXNORM":"24942","UMLSCUI":"C0060277","chemblId":"CHEMBL3833303","ChEMBL_ID":"CHEMBL3833303","KEGG_DRUG":"D02394","DRUGBANK_ID":"DB14488","PUBCHEM_CID":"23616740","SNOMEDCT_US":"116130008","SECONDARY_CAS_RN":"34089-81-1","MESH_SUPPLEMENTAL_RECORD_UI":"C011819"},"formularyStatus":[],"originalProduct":{"form":"INJECTION","route":"INTRAVENOUS","company":"sanofi-aventis  U.S. LLC","brandName":"Ferrlecit","isOriginal":true,"marketingStatus":"NDA"},"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"1999-","companyName":"Sanofi","relationship":"Original Developer"}],"publicationCount":142,"therapeuticAreas":["Hematology"],"atcClassification":{"source":"DrugCentral","atcCode":"B03AA03","allCodes":["B03AA03","B03AD05"]},"biosimilarFilings":[],"originalDeveloper":"Sanofi Aventis Us","recentPublications":[{"date":"2026 Mar 16","pmid":"41839045","title":"Fat Apoptosis Injection Therapy for Infraorbital Herniated Fat Pads.","journal":"The Journal of craniofacial surgery"},{"date":"2006","pmid":"34958537","title":"Iron Salts.","journal":""},{"date":"2026 Apr 15","pmid":"41679208","title":"Evaluation of iron supplementation effects of whey protein peptide-ferrous chelate: enhancing bioavailability and antioxidant capacity, promoting gut microbiota balance.","journal":"Food chemistry"},{"date":"2026","pmid":"41660502","title":"Oral iron preparations: gastrointestinal adverse events and medication adherence in female patients with iron deficiency anemia.","journal":"Frontiers in pharmacology"},{"date":"2025","pmid":"41347233","title":"Economic evaluation of intravenous iron formulations for patients with iron deficiency anemia: a systematic review.","journal":"Frontiers in health services"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"Sanofi","companyId":"sanofi","modality":"Small molecule","firstApprovalDate":"1999","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1999-02-18T00:00:00.000Z","mah":"SANOFI AVENTIS US","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"BR","regulator":"ANVISA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MX","regulator":"COFEPRIS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AR","regulator":"ANMAT","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TR","regulator":"TITCK","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IN","regulator":"CDSCO","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TH","regulator":"FDA-TH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MY","regulator":"NPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"PH","regulator":"FDA-PH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CO","regulator":"INVIMA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"ZA","regulator":"SAHPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TW","regulator":"TFDA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"HK","regulator":"DH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":2,"lastValidatedAt":"2026-04-20T01:58:04.219858+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}